Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities
暂无分享,去创建一个
Tatsuhiko Tsunoda | Hariklia Eleftherohorinou | Nagib Dahdah | Michael Levin | Michiaki Kubo | David Burgner | Martin L Hibberd | Atsushi Takahashi | Todd A. Johnson | Rolando Cimaz | Jane C Burns | Jihoon Kim | L. Coin | Toshihiro Tanaka | T. Tsunoda | M. Kubo | N. Dahdah | Jihoon Kim | C. Khor | A. Takahashi | V. Wright | M. Hibberd | M. Levin | J. Burns | A. Tremoulet | T. Kuijpers | M. Alphonse | R. Yeung | R. Cimaz | T. A. Johnson | D. Burgner | H. Eleftherohorinou | J. Perry | C. Shimizu | S. Davila | Toshihiro Tanaka | Yoshihiro Onouchi | Victoria J Wright | Lachlan J M Coin | Taco W Kuijpers | Chisato Shimizu | Rae S M Yeung | Sonia Davila | Y. Onouchi | Chiea Chuen Khor | L. Hoang | A. Salgado | Adriana H Tremoulet | Martin P Alphonse | James C Perry | Long T Hoang | Andrea Salgado | Todd A Johnson | M. Kubo
[1] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[2] P. Hegyi,et al. Na+/Ca2+ exchangers regulate the migration and proliferation of human gastric myofibroblasts. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[3] S. Shaughnessy,et al. Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.
[4] H. Rahamimoff,et al. Cyclosporin A‐Dependent Downregulation of the Na+/Ca2+ Exchanger Expression , 2007, Annals of the New York Academy of Sciences.
[5] Yoshihiro Onouchi,et al. Genetics of Kawasaki disease: what we know and don't know. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[6] Yusuke Nakamura,et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.
[7] Yu-guang Li,et al. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta , 2008, Journal of hypertension.
[8] M. Triggiani,et al. Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes , 2009, European journal of immunology.
[9] H. Krum,et al. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. , 2010, American journal of physiology. Heart and circulatory physiology.
[10] P. Conlin,et al. Na+/Ca2+ Exchanger Activity Modulates Connective Tissue Growth Factor mRNA Expression in Transforming Growth Factor β1- and Des-Arg10-kallidin-stimulated Myofibroblasts* , 2005, Journal of Biological Chemistry.
[11] Tien Yin Wong,et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease , 2011, Nature Genetics.
[12] J. Burns,et al. Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms. , 2015, International journal of cardiology.
[13] A. Tremoulet. The role of statins in inflammatory vasculitides , 2015, Autoimmunity.
[14] Kei Takahashi,et al. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[15] A. Hata,et al. Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin , 2011, The Pediatric infectious disease journal.
[16] J. Kimura,et al. Lysophosphatidylcholine increases Na+/Ca2+ exchanger expression via RhoB-geranylgeranylation in H9c2 cells. , 2009, Journal of pharmacological sciences.
[17] C. Aalkjær,et al. Vascular smooth muscle cell phenotype is defined by Ca2+‐dependent transcription factors , 2013, The FEBS journal.
[18] M. Berridge,et al. Calcium: Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature Reviews Molecular Cell Biology.
[19] J. Orenstein,et al. Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study , 2012, PloS one.
[20] Scott Mellis,et al. Transforming Growth Factor-&bgr; Signaling Pathway in Patients With Kawasaki Disease , 2011, Circulation. Cardiovascular genetics.
[21] Hariklia Eleftherohorinou,et al. Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. , 2011, Human molecular genetics.
[22] Libiao Wu,et al. Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta. , 2010, Chinese medical journal.
[23] J. Burns,et al. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. , 2013, Human pathology.
[24] Toshihiro Tanaka,et al. Variations in ORAI1 Gene Associated with Kawasaki Disease , 2016, PloS one.
[25] A. Hata,et al. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial) , 2015, BMJ Open.
[26] J. Kimura,et al. Involvement of Na+/Ca2+ exchanger in migration and contraction of rat cultured tendon fibroblasts , 2009, The Journal of physiology.
[27] Y. S. Cho,et al. A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval. , 2012, American journal of human genetics.
[28] Yun‐Min Zheng,et al. Sodium–Calcium Exchanger in Pulmonary Artery Smooth Muscle Cells , 2007, Annals of the New York Academy of Sciences.
[29] R. Uehara,et al. Epidemiology of Kawasaki Disease in Asia, Europe, and the United States , 2012, Journal of epidemiology.
[30] C. Hoggart,et al. Pathway Analysis of GWAS Provides New Insights into Genetic Susceptibility to 3 Inflammatory Diseases , 2009, PloS one.
[31] J. Newburger,et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.
[32] Ross M. Fraser,et al. A General Approach for Haplotype Phasing across the Full Spectrum of Relatedness , 2014, PLoS genetics.
[33] J. Newburger,et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. , 2013, International journal of cardiology.
[34] C. Khor,et al. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease , 2014, Genome Medicine.
[35] Paul D. Mitchell,et al. Coronary Artery Involvement in Children With Kawasaki Disease: Risk Factors From Analysis of Serial Normalized Measurements , 2007, Circulation.
[36] J. Kimura,et al. Down-Regulation of Na+/Ca2+ Exchanger by Fluvastatin in Rat Cardiomyoblast H9c2 Cells: Involvement of RhoB in Na+/Ca2+ Exchanger mRNA Stability , 2005, Molecular Pharmacology.
[37] Yusuke Nakamura,et al. A genome-wide association study identifies three new risk loci for Kawasaki disease , 2012, Nature Genetics.
[38] B. Quednau,et al. Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. , 1997, The American journal of physiology.
[39] P. Pacaud,et al. Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes1 , 2007, The Journal of Immunology.
[40] K. Yabuta,et al. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.